key: cord-0973806-k0zqpfgf authors: Yashvardhini, Niti; Kumar, Amit; Jha, Deepak Kumar title: Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies date: 2021-12-03 journal: Vacunas DOI: 10.1016/j.vacun.2021.10.002 sha: 8e7f1931bdc321c9395e71291f1e190fa74e642e doc_id: 973806 cord_uid: k0zqpfgf SARS-CoV-2 (Severe Acute Respiratory syndrome), an etiolating agent of novel COVID-19 (coronavirus 2019) pandemic, rapidly spread worldwide and creating an unprecedented public health crisis globally. NSP5, the main viral protease, is a highly conserved protein, encoded by the genome of SARS-CoV-2 and plays an important role in the viral replication cycle. In the present study, we detected a total of 33 mutations from 675 sequences submitted from India in the month of March 2020 to April 2021. Out of 33 mutations, we selected 8 frequent mutations (K236R, N142L, K90R, A7V, L75F, C22N, H246Y, and I43V) for further analysis. Subsequently, protein models were constructed, revealing significant alterations in the 3-D structure of NSP5 proteins when compared to the wild type protein sequence which also altered the secondary structure of NSP5 protein. Further, we identified 9 B-cell, 10 T-cell and 6 MHC-I promising epitopes using predictive tools of immunoinformatics and some were non-allergenic as well as highly immunogenic. Results of our study, however, revealed that 10 B-cell epitopes reside in the mutated region of NSP5. Additionally, hydrophobicity, physiochemical properties, toxicity and stability of NSP5 protein were estimated to demonstrate the specificity of the multiepitope candidates. Taken together, variations arising as a consequence of multiple mutations may cause alterations in the structure and function of NSP5 which generate crucial insights to better understand structural aspects of SARS-CoV-2. Our study also revealed, NSP5, a main protease, can be a potentially good target for the design and development of vaccine candidate against SARS-CoV-2. reside in the mutated region of NSP5. Additionally, hydrophobicity, physiochemical properties, toxicity and stability of NSP5 protein were estimated to demonstrate the specificity of the multiepitope candidates. Taken together, variations arising as a consequence of multiple mutations may cause alterations in the structure and function of NSP5 which generate crucial insights to better understand structural aspects of SARS-CoV-2. Our study also revealed, NSP5, a main protease, can be a potentially good target for the design and development of vaccine candidate against SARS-CoV-2. El SARS-CoV-2 (Síndrome Respiratorio Agudo Severo), un agente etiológico de la nueva pandemia de COVID-19 (coronavirus 2019), se propagó rápidamente por todo el mundo y creó una crisis de salud pública sin precedentes a nivel mundial. El NSP5, la proteasa viral principal, es una proteína altamente conservada, codificada por el genoma del SARS-CoV-2 y juega un papel importante en el ciclo de replicación viral. En el presente estudio se detectaron un total de 33 mutaciones de 675 secuencias presentadas desde la India en el mes de marzo de 2020 a abril de 2021. De 33 mutaciones, se seleccionaron 8 mutaciones frecuentes (K236R, N142L, K90R, A7V, L75F, C22N, H246Y e I43V) para su posterior análisis. Posteriormente, se construyeron The rapid emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for causing the ongoing pandemic of novel coronavirus disease 2019 (COVID- 19) , induces moderate to severe respiratory distress (such as cough, cold, dyspnea) in humans around the world. 1 The novel COVID-19 has been reported from the wildlife market in Wuhan city of infection and pathogenesis. Present in silico study was, therefore, carried out to detect and characterize mutations of NSP5 of SARS-CoV-2. We identified a total of 33 mutations from 675 sequences submitted from India in the month of March 2020 to April 2021 and compared with the first reported sequence from Wuhan, as a reference sequence. Subsequently, the impact of mutation on the secondary structure and protein dynamics was observed that help in designing therapeutics and/or vaccine to curb SARS-CoV-2 infections. In addition to this, NSP5 of SARS-CoV-2 was explored to determine the potent antigenic epitopes of B-cell and T-cell with their MHC alleles to predict multiepitope vaccine (MEV) construct. Owing to their specificity, stability, less time consuming and cost effective properties as well as ability to induce significant humoral and cellular immune responses, MEVs are found to be advantageous over single epitope or conventional vaccine development approach. 17 Further, several predictive tools of immunoinformatics were utilized to validate the nonallergenic, non-toxic, antigenicity, toxicity, structural stability/flexibility and physiochemical properties and hydrophobicity of the designed multi-epitopes vaccine candidate. The full length protein sequence of ORF1ab polyprotein, 7096 amino acid long which encodes for non structural proteins in SARS-COV-2 were retrieved from NCBI virus database. NCBI virus database keeps a deposit of all SARS-CoV-2 sequences submitted from different parts of the world. As on 29 th April 2021, 675 full length ORF1ab amino acid sequences were submitted from India which was used in this study. The first reported ORF1ab protein sequence with Accession number YP_009724389 was also downloaded to be used as a reference or wild type J o u r n a l P r e -p r o o f sequence in this study. From the full length ORF1ab polyprotein sequence, the sequence of NSP5 (SARS-CoV-2 protease) was procured being 306 amino acid long. To detect the variations in the protease protein amino acid sequences, the NSP5 protein sequences from India were aligned with the first reported SARS-CoV-2 sequence from Wuhan. To align these polypeptides, Clustal Omega online platform 18 was used which creates 1000 of alignments based on HMM profile seeded guide trees. These alignments were viewed on Jalview to detect the variations occurring in the protease protein with reference to Wuhan type protease sequence. The non-synonymous amino acid variants were analyzed using Protein Variation Effect Analyzer known as PROVEAN v1.1.3 with cutoff predicted score of -2.50 to detect the effect of mutation on the NSP5 protein. 19 PROVEAN predicts the effect of amino acid substitution on the overall function of aa protein. A score namely delta alignment is calculated which are the PROVEAN scores of the substituted protein. The threshold limit for this score being -2.5 below or equal to which the mutation is deleterious and above this threshold limit the variation has neutral effect. The secondary structure of the NSP5 protein was predicted using CFSSP (Chou and Fasman Secondary Structure Prediction) online software. 21 The analysis was done for both wild type and mutated protein sequences to study the alteration in the secondary structure of the protein such as changes in helix, turn and sheet formation due to mutation. Phyre2 online modeling platform was used to build the models of wild type and mutated NSP5 proteins. 22 Dynamut software was applied to detect the impact of mutation on the structure flexibility and dynamicity of NSP5 protein. 23 Dynamut computes information on the stability, NMA analysis, flexibility, rigidness, conformation of mutated as well as wild type protein. Several parameters were calculated like flexibility analysis, vibrational entropy, atomic and deformation energies using first 10 non-trivial modes of the structure. To check whether upon variation intramolecular interactions can change, Dynamut was used to predict the effect of mutation on intramolecular interactions. IEDB was used to predict the linear B-cell epitopes in the NSP5 protein of SARS-CoV-2. 24 IEDB webserver constructs epitopes based on estimation of parameters like flexibility, accessibility, hydrophilicity, turns, polarity and antigenic propensity of the protein using amino acid scales and HMMs. J o u r n a l P r e -p r o o f The T-cell epitope binding alongwith the detection of MHC allele showing highest affinity for the T-cell epitope was predicted using IEDB Tepitool server. 24 This platform provides information on the binding of HLA allele with both type I and type II MHC molecules. To identify the antigenicity of the NSP5 protein, Vaxijen v2.0 server which predicts antigens according to the auto cross-covariance (ACC) transformation of the protein sequences was used. 25 The prediction of vaccine allergenicity was done using AllerTOP server, which evaluates protein allergenicity on auto cross variance (ACC method) that explains residues hydrophobicity, size, flexibility and other parameters. 26 Altogether 675 full length sequences of ORF1ab were submitted from India from March 2020 till April 2021. These 675 sequences were downloaded alongwith a reference sequence of Wuhan type virus from NCBI virus database (Supplementary Table 1 ). The multiple sequence alignment was performed for all these ORF1ab sequences with reference to Wuhan type virus and the alignment file was viewed using Jalview. Those mutations which occurred in NSP5 were recorded and used for further analysis. A total of 33 point mutations were detected in this 306 amino acid long NSP5 protein of Indian isolates (Supplementary Table 2 Table 3) . The physicochemical properties of SARS-CoV-2 protease protein were estimated using Protparam (ExPasy). The analysis revealed that the NSP5 protein is 306 amino acids in length with a molecular weight of 33796.64 Da, instability index 27.65, aliphatic index 82.12 and GRAVY score of -0.019 (Table 1 ). The hydropathy plot showed C-terminal amino acid to be more hydrophobic as compared to the N-terminal end of NSP5 protein (Fig. 1) . To detect the alteration in formation and loss of alpha helix, beta sheet and turns upon mutation in NSP5 protein secondary structure prediction was done using CFSSP online program with acid has more tendencies to form sheets rather than helix. Overall; the secondary structure analysis depicts significant changes in the formation and loss of helix, sheet and turn that can bring huge impact on NSP5 protein and hence leading to the SARS-CoV-2 multiplication and infection. The 3D model of NSP5 protein was built using Phyre2 online modeling software, which performs modeling on the basis of template search. The template being used for protease protein was d2duca1 with 100% similarity coverage. The models of both wild type and mutated NSP5 protein sequences are shown in Supplementary Fig. 2 . The impact of mutation on the dynamics of protease protein was estimated using Dynamut software (Rodrigues et al. 2018) . Dynamut software estimates the flexibility or steadiness of a protein upon mutation as compared to the wild type as calculated by ENCoM, DUET, mCSM and others. Negative value of ΔΔG denotes destabilization of protein upon mutation, whereas a positive value signifies stabilization. The free energy difference, ∆∆G between the wild and mutated protein sequences was calculated using Dynamut and the values showed a stabilizing mutation in five mutants of NSP5 protein as indicated by their ∆∆G values ( Table 2) mutants, shown by red color region in the Fig. (Fig. 2c) . Further, the findings of our study dealt with the detection of variation in intramolecular interactions of NSP5 protein with its neighbouring molecules upon mutation. All the NSP5 mutants studied here showed significant changes in intramolecular interactions that occurred in NSP5 proteins upon mutation (Fig. 2d) . The mutation caused significant alterations in the interactions like hydrogen bonds, ionic interactions, hydrophobic interactions and other metal complex interactions. The substitution in side chain of the amino acids changes due to mutation Linear B-cell epitopes were predicted for NSP5 protein using NSP5 protein sequence as query and threshold value of 0.5 was selected. A total of 8 B-cell epitopes predicted for this protein above the threshold value which are shown in table 3 (Fig. 3a) . Out of these nine epitopes, the epitopes KMAFPSGKV, EDMLNPNYEDL, QNGMNG and EFTPFDVVR were highly antigenic as well as non-allergenic, whereas some epitopes were immunogenic but allergenic. These five predicted epitopes can be a good candidate in vaccine production against SARS-CoV-2. In our analysis 9 mutations out of 33 were found in the epitopic region of protease protein.These mutations not only change its epitopc region rather changes its overall antigenicity and therefore can help in host evasion. Altogether 9 T-cell binding epitopes were predicted for NSP5 protein showing different allele binding affinity. The sequence of these epitopes along with its position is shown in Table 4 . Out of these nine T-cell epitopes only two were allergenic and others were immunogenic as well as non-allergenic. The MHC class I immunogenicity of the NSP5 molecules is shown in table 5. A total of 6 peptides were predicted with a potential of MHC class I immunogens. These epitopes can induce immunogenicity and hence increase cytokine production in cells to combat the infection. The cluster analysis of MHC class I allele is shown in Fig. 3c while that of class II allele is shown in Fig. 3d , where the red zone denotes strong interaction of the HLA allele with the J o u r n a l P r e -p r o o f epitopes of NSP5 protein whereas yellow depicts weak interaction. We analyzed the binding ability of all the alleles with the protease epitopes. can be a candidate protein for vaccine development. Coronavirus poses an unprecedented threat for human health globally. Considering its contagiousity, World Health Organization on 11 th March 2020 has declared public health emergency internationally (WHO 2020). SARS-CoV-2 is a member of RNA viruses and has remarkable capacity to mutate their genome in a very short period of time. 27 Notably, majority of viral mutation shows harmful effects. Moreover, a mutation is essential for viral evolution and adaptability, these traits are considered as the key determinants for viruses to survive in the dynamic environment host and also enabling them to evade the pre-existing immunity of host and most often acquire drug resistance. SARS-CoV-2 infections emerged from Wuhan, China, soon began to spread globally. Rapid transmission of coronavirus infection depends on various factors such as polymerase fidelity, different geographical areas, and population density, as well as poor health care system, climatic and environmental variations. 28 findings of earlier studies suggested that protein could be a very good target for developing vaccine against SARS-CoV-2. 33, 34 Additionally, for a peptide vaccine to be highly immunogenic B-cell epitope of its target molecule must interact with a T-cell immune epitope. The T-cell epitopes is made up of short fragments of peptide and hence appeared as more propitious, which generate long term immune response mediated by CD8+ T-cells. 6 In contrast, the B-cell epitopes consists of linear chain of amino acid. 35, 36 The epitope selection based on immunogenic features like antigenicity, allergenicity and toxicity. Similarly, the predicted antigenic determinants (epitopes) of MHC class-I showed interaction with the several HLA alleles and, therefore, found to be antigenic. The hydropathy index and physiochemical properties of SARS-CoV-2 NSP5 protein were also estimated which revealed that protein is stable and can form non-covalent bonds (such as hydrogen bonds) with other protein molecules. The present in silico study was found consistent with the previous studies based on immunoinformatics approach for the design and developments of novel therapeutic intervention and/or vaccine against COVID-19. [37] [38] [39] [40] In this study, we investigated the NSP5, as a potent immunogenic epitopes which elevates prolonged humoral (B cell) as well as cell mediated (T cell) immune response to counteract viral particles, and hence serves as a potential candidate vaccine. A total of 8 B-cell and T-cell epitopes were predicted for NSP5 proteins, amongst which the epitopes KMAFPSGKV, EDMLNPNYEDL, QNGMNG and EFTPFDVVR were highly immunogenic as well as non-allergenic. Primarily, the efficacy of vaccine candidates relies on the selection of its antigen molecules. 41 The data obtained from our study also corroborates the previous findings. Earlier studies on SARS-CoV and MERS-CoV have shown that the S glycoprotein can induce antibodies to neutralize virus infection by blocking virus binding as well as its fusion to the host J o u r n a l P r e -p r o o f cell. 41 Yashvardhini et al. (2021) 17 have also reported that multiepitopes based peptide vaccines are safe and specific that need adjuvants to show high levels of immunogenicity. In the present study, occurrence of recurrent mutations in the main viral protease (NSP5) of coronavirus elucidates structural alteration that might affect its functions. Using predictive tools of computational biology, we also predicted promising epitope based vaccine candidates No conflict of interest. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding A Novel Coronavirus from Patients with Pneumonia in China Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing A new coronavirus associated with human respiratory disease in China SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity The proteins of severe acute respiratory syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19 Coronaviruses: an overview of their replication and pathogenesis Virus-encoded proteinases and proteolytic processing Intracellular and in vitro-translated 27-kDa proteins contain the 3C-like proteinase activity of the coronavirus MHV-A59 Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors Structure of M pro from SARS-CoV-2 and discovery of its inhibitors Immunoinformatics Identification of B-and T-Cell Epitopes in the RNA-Dependent RNA Polymerase of SARS-CoV-2 The EMBL-EBI search and sequence analysis tools APIs in 2019 PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels The Phyre2 web portal for protein modeling, prediction and analysis DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability Immune epitope database analysis resource A server for prediction of protective antigens, tumour antigens and subunit vaccines AllerTOP-a server for in silico prediction of allergens The 2019-new coronavirus epidemic: Evidence for virus evolution Temperature significant change COVID-19 transmission in 429 cities Temperature-sensitive mutants and revertants in the coronavirus nonstructural protein 5 protease (3CLpro) defne residues involved in long-distance communication and regulation of protease activity A new cistron in the murine hepatitis virus replicase gene A new coronavirus associated with human respiratory disease in China Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers Phylogenetic analysis and structural perspectives of RNA-dependent RNA-polymerase inhibition from SARs-CoV-2 with natural products Mutation analysis of the cross-reactive epitopes of Japanese encephalitis virus envelope glycoprotein The spike protein of SARSCoV -a target for vaccine and therapeutic development Nil. No conflict of interest. Nonallergen J o u r n a l P r e -p r o o f